Barbara Ann Karmanos Cancer Institute

Detroit, Maine 48201-2013

1 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumors, Breast Cancer, Non-Hodgkin's Lymphoma, Solid Cancers

Studies at this site

• A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer — Recruiting now
• A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors — Completed
• A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer — Stopped early